(After all, he says, «
a huge number of drugs we give are black boxes.»)
Not exact matches
While some
of the firm's flagship treatments are facing patent expiration, Saunders has been on a quest to snap up a
huge number of biotechs developing
drugs for liver disease, Alzheimer's, and other conditions.
If you want to produce a
drug, it may take a
huge number of chemical steps — so many that it's not economically feasible using just chemistry.
My question — Why isn't the Chamber raising questions about the
huge number of patients who saw television advertisements from Xarelto's manufacturer, began taking the
drug and then suffered an uncontrolled bleeding injury?